NCT00908154View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of Repeat Doses of GSK1014802.

PHASE1CompletedINTERVENTIONAL

Enrollment

51

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Bipolar DepressionBipolar Disorder

Interventions

DRUG

Placebo

Tablets to match GSK1014802

DRUG

GSK1014802

Sodium channel blocker

Trial Locations (1)

SE1 1YR

GSK Investigational Site, London

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Biogen

INDUSTRY